US Patent Issued to Janssen Biotech on Oct. 20 for "Vaccines based on mutant CALR and JAK2 and their uses" (American, Dutch Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,767,934, issued on Oct. 20, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"Vaccines based on mutant CALR and JAK2 and their uses" was invented by Ricardo Attar (Lawrenceville, N.J.), Jason Dehart (San Diego), Selina Khan (Leiden, Netherlands), Vinod Krishna (Philadelphia), Jenifer Lum (Castro Valley, Calif.), Christian Maine (San Diego), Barbara Sanders (Amsterdam), Manuel Alejandro Sepulveda (West Windsor, N.J.), Patrick Wilkinson (Collegeville, Pa.) and Roland Zahn (Rijnsburg, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are vaccines, polypeptides and polynucleotides based on mutant CALR and JAK2 sequences, vectors, host ...